Can a thyroid panel with high free T3, normal free T4, and high TSH reflect assay interference or preanalytical variation?

Discordant thyroid tests are clinically important because they can prompt inappropriate labeling as thyroid disease if interpreted as a single physiological state. In a 24-year-old man with elevated free T3 (FT3), preserved free T4 (FT4), and elevated TSH, confirmation is warranted before treatment or investigation for rare intrinsic disorders.

Clinical interpretation and verification

• This combination is biochemically discordant: genuine thyroid hormone excess would generally be expected to suppress TSH. A single panel therefore should not be treated as definitive evidence of stable thyroid physiology.
• Repeat TSH, FT3, and FT4 on a fresh specimen under standardized conditions is the immediate practical step. Collection timing matters particularly for TSH, which has meaningful within-person biologic variation.
• If discordance persists, testing with an assay from a different manufacturer/platform is central. A material inter-platform difference strongly supports assay interference.
• Laboratory investigations can include serial dilution for nonlinearity and heterophile-blocking studies. If uncertainty remains, equilibrium dialysis or ultrafiltration with LC-MS/MS free-hormone measurement can reduce susceptibility to immunoassay artifacts.

Analytical mechanisms

• Heterophile or related antibodies can spuriously elevate TSH in immunoassays.
• Anti-iodothyronine/anti-thyroid-hormone antibodies, anti-animal antibodies, or antibodies directed at assay reagents can cause assay-dependent falsely high FT3 (and sometimes FT4). These analyte-specific effects can produce the apparent FT3–TSH mismatch without one unifying thyroid disorder.
• Biotin may falsely raise free-hormone measurements in susceptible competitive assays, but it usually lowers TSH, so it does not alone explain this pattern.

Clinical context

• Review supplements, medications, acute illness/recovery, sampling timing, and specimen handling. Illness more commonly lowers FT3, though TSH can rise transiently during recovery.

Bottom line

• Analytical interference is a supported explanation; preanalytical variation is plausible. Repeat, appropriately collected testing—preferably including an alternative assay platform—should precede conclusions about stable thyroid physiology or treatment.